# Quick Reference: Adequacy Assessment Decision

**Date**: 2025-10-30
**Status**: Phase 5 Complete
**Decision**: CONTINUE to Experiment 3 (AR(2))

---

## Key Documents (In Order of Priority)

### 1. Decision Documents
- **DECISION**: `/workspace/experiments/DECISION_SUMMARY.md` ⭐⭐⭐
  - Executive summary, one-page decision rationale
  - Start here for quick understanding

- **FULL ASSESSMENT**: `/workspace/experiments/adequacy_assessment.md` ⭐⭐⭐
  - Comprehensive 35-page analysis
  - Read for complete reasoning and evidence

- **PROJECT OVERVIEW**: `/workspace/experiments/README.md` ⭐⭐
  - Project structure, navigation, timeline
  - Read for context and file locations

### 2. Model Decisions
- **Experiment 2 Decision**: `/workspace/experiments/experiment_2/model_critique/decision.md`
  - Why AR(1) is conditionally accepted
  - 7 key reasons, limitations, use cases

- **Experiment 1 Decision**: `/workspace/experiments/experiment_1/model_critique/decision.md`
  - Why Negative Binomial GLM rejected
  - 5 key reasons, falsification criteria met

### 3. Comparison
- **LOO-CV Comparison**: `/workspace/experiments/model_comparison/comparison_report.md`
  - Exp 2 wins by ΔELPD = +177.1 ± 7.5 (23.7 SE)
  - 6 diagnostic visualizations
  - Multi-criteria trade-off analysis

### 4. Technical Results
- **Exp 2 Quick Results**: `/workspace/experiments/experiment_2/posterior_inference/RESULTS.md`
  - Parameter estimates, diagnostics
  - Residual ACF = 0.549 (key finding)

- **Exp 2 Full Inference**: `/workspace/experiments/experiment_2/posterior_inference/inference_summary.md`
  - Detailed parameter posteriors
  - Convergence diagnostics
  - Predictive performance

- **Exp 2 PPC**: `/workspace/experiments/experiment_2/posterior_predictive_check/ppc_report.md`
  - All 9 tests pass
  - 100% coverage, perfect calibration

---

## The Decision in 3 Bullets

1. **Experiment 2 (AR(1)) is substantially better** than baseline (+177 ELPD, 12-21% lower errors)
2. **But has diagnosed limitation** (residual ACF = 0.549 > 0.3 threshold)
3. **AR(2) is obvious next step** (low cost, clear benefit, completes logical arc)

**Conclusion**: Continue to Experiment 3 before declaring adequacy.

---

## Critical Numbers

| Metric | Value | Interpretation |
|--------|-------|----------------|
| **ΔELPD (Exp 1→2)** | +177.1 ± 7.5 | 23.7 SE, overwhelming |
| **MAE Improvement** | 16.53 → 14.53 | 12% better predictions |
| **Residual ACF** | 0.549 | Exceeds 0.3 threshold |
| **Falsification Criteria Met** | 1 of 6 | Borderline but diagnostic |
| **Confidence in Decision** | 85% | HIGH |
| **Expected AR(2) Benefit** | ΔELPD ~ 20-50 | Moderate to substantial |
| **Time to Exp 3** | 1-2 days | Low cost |

---

## Stopping Rule for Experiment 3

**ACCEPT AR(2)** if:
- Residual ACF < 0.3, OR
- ΔELPD vs AR(1) > 10 AND ACF < 0.4

**ACCEPT AR(1)** if:
- AR(2) shows ΔELPD < 10, OR
- AR(2) has convergence issues

**Then**: Proceed to Phase 6 (Final Reporting)

**No Experiment 4** planned (stopping rule prevents endless iteration)

---

## Key File Paths

### InferenceData (Posterior Samples)
- Experiment 1: `/workspace/experiments/experiment_1/posterior_inference/diagnostics/posterior_inference.netcdf`
- Experiment 2: `/workspace/experiments/experiment_2/posterior_inference/diagnostics/posterior_inference.netcdf`

### Visualizations
- Model Comparison: `/workspace/experiments/model_comparison/visualizations/`
  - `loo_comparison.png` - ELPD comparison
  - `fitted_comparison.png` - Model fits
  - `model_trade_offs.png` - Multi-criteria spider plot
  - `calibration_comparison.png` - LOO-PIT diagnostics
  - `pareto_k_comparison.png` - LOO reliability
  - `prediction_intervals.png` - Uncertainty quantification

### Code
- Experiment 1: `/workspace/experiments/experiment_1/posterior_inference/code/fit_model_pymc.py`
- Experiment 2: `/workspace/experiments/experiment_2/posterior_inference/code/fit_model_final.py`
- Comparison: `/workspace/experiments/model_comparison/code/run_comparison.py`

---

## Why CONTINUE (Not ADEQUATE or STOP)?

### 8 Reasons to Continue
1. Pre-specified falsification criterion met (ACF > 0.3)
2. Clear improvement path (AR(2) structure)
3. Low marginal cost (1-2 days, reuse infrastructure)
4. Moderate expected benefit (ΔELPD ~ 20-50)
5. Recent improvement substantial (+177, not diminishing)
6. Scientific rigor (test recommendation before concluding)
7. Haven't explored obvious alternative (AR(2))
8. Scientific interpretation changes (1-period vs 2-period memory)

### NOT ADEQUATE Because
- Only 1 of 6 falsification criteria met, but it's critical
- Clear path exists to address limitation
- "Good enough for now" ≠ "Good enough to stop"
- Publication reviewers would ask "Did you try AR(2)?"

### NOT STOP Because
- No fundamental failure (AR(1) conditionally succeeded)
- No data quality issues or computational barriers
- Not in diminishing returns phase (last gain +177 ELPD)
- Different methods not needed (Bayesian approach working)

---

## Timeline

- **2025-10-30**: Experiments 1-2, comparison, adequacy assessment
- **2025-10-31 (Target)**: Experiment 3 (AR(2)) design and implementation
- **2025-11-01 (Target)**: Experiment 3 validation and final assessment
- **2025-11-01+**: Phase 6 (Final Reporting)

---

## For Quick Communication

**One-Sentence Summary**:
"Experiment 2 is substantially better than baseline and fit for current use, but has a diagnosed limitation (residual ACF = 0.549) with a clear fix (AR(2)) at low cost—one more experiment before declaring adequacy."

**Decision**: CONTINUE

**Confidence**: HIGH (85%)

**Next Action**: Design and implement Experiment 3 (AR(2) structure)

**Expected Outcome**: Accept AR(2) as final model OR accept AR(1) with evidence that AR(2) didn't help

**Then**: Proceed to Phase 6 (Final Reporting)

---

**Last Updated**: 2025-10-30
**Status**: FINAL - Ready for Experiment 3
